Abstract
Intraocular lenses (IOL) that filter some blue light were introduced in the 1990s and were suggested to reduce the risk of Age related macular degeneration and uveal melanoma. The potential benefits and harm from blocking blue light has been debated. In this chapter we will discuss the evidence for the protective effects and the negatives of these IOLs.
Keywords: Intraocular lens, blue light, macular degeneration, color vision, lipofuscin, melanoma, insomnia, melatonin, melanopsin, retinal damage, phototoxicity, compliment system, antioxidants, cataract, oncogenesis, scotopic vision, mesopic vision, circadian rhythm, suprachiasmatic nuclei, depression.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Alzheimer Research
Current Aging Science
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents